Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 152,989 | 171,526 | 55,556 | 72,675 | 86,212 |
| TOTAL | $154,995 | $173,421 | $56,501 | $73,732 | $89,242 |
| Non-Current Assets | |||||
| PPE Net | 2,982 | 2,905 | 2,996 | 2,820 | 2,910 |
| Other Non-Current Assets | 174 | 130 | 130 | 130 | 130 |
| TOTAL | $3,156 | $3,035 | $3,126 | $2,950 | $3,040 |
| Total Assets | $158,151 | $176,456 | $59,627 | $76,682 | $92,282 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,735 | 2,987 | 2,383 | 2,549 | 1,475 |
| Accrued Expenses | 8,556 | 8,626 | 5,174 | 6,542 | 7,131 |
| TOTAL | $16,450 | $16,590 | $11,626 | $13,620 | $11,274 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $16,450 | $16,590 | $11,626 | $13,620 | $11,274 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,971 | 35,686 | 29,633 | 29,531 | 29,180 |
| Common Shares | 359 | 356 | 296 | 292 | 292 |
| Retained earnings | -381,586 | -358,914 | -335,807 | -315,237 | -294,613 |
| TOTAL | $141,701 | $159,866 | $48,001 | $63,062 | $81,008 |
| Total Liabilities And Equity | $158,151 | $176,456 | $59,627 | $76,682 | $92,282 |